Catalpol Ameliorates Myocardial I/R Injury Through PI3k/Akt/P53 Signaling-mediated Anti-autophagy and Anti-apoptosis
Lingai Hu1★, Yukun Sun2, Hongsheng Zhang1, Yong Cao1, Jinguo Zhang1★ Corresponding author
- 1Department of Cardiology, The Affiliated Hospital of Jining Medical College, Jining, Shandong, China
- 2Department of Prosthodontics, Jining Stomatology Hospital, Jining, Shandong, China
CORRESPONDENCE
Lingai Hu
Department of Cardiology, The Affiliated Hospital of Jining Medical College, No. 89, Guhuai Road, Rencheng District, Jining, Shandong, China.
Received: 02-02-2023; Accepted: 02-06-2023.
Volume 19, Issue 4 · pp. 946–953 · PUBLISHED 2023 · DOI: 10.1177/09731296231189557
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: Myocardial infarction (MI) is a leading cardiovascular disease worldwide, with high mortality. Purpose: The study aimed to observe the mechanism of catalpol inhibiting apoptosis and autophagy in H9c2 cells after ischemia/reperfusion (I/R) injury. Materials and Methods: We grouped H9c2 cells into 4 groups: control, I/R injury, catalpol (I/R injury +1 ug/mL catalpol treatment), and wortmannin (I/R injury + 1 ug/mL catalpol +150 nM wortmannin treatment) groups. Both catalpol and wortmannin group cells were given drug treatment 30 min before I/R injury. At 2h post-I/R insult, we used flow cytometry for detecting cellular apoptosis and reactive oxygen species (ROS) levels. We identified p-PI3K, p-Akt, PI3K, Akt, p53, Bcl-2, Caspase-3, Bax, beclin1, LC3II, and LC3I protein expression levels. Results: I/R significantly increased the apoptosis rate and ROS level of H9c2 cells, increased expression levels of p53, LC3II/LC3I, and Caspase-3, and decreased p-Akt/Akt, beclin1, Bcl-2/Bax, and p-PI3K/PI3K expression levels. Catalpol can reduce the expressions of p53, Caspase-3, and LC3II/LC3I (p < 0.5). Catalpol can increase the expression levels of Akt/ p-Akt, Bax/ Bcl-2, and beclin1. Also, it can inhibit apoptosis and autophagy levels of H9c2 cells (p < 0.5). Wortmannin, a PI3 K-specific inhibitor, was able partially to block the catalpol’s and anti-autophagic and anti-apoptotic effects. Conclusion: Catalpol can inhibit apoptosis, reduces excessive autophagy, and alleviates the effects of myocardial ischemia-reperfusion through PI3K/Akt/p53 pathway.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Hu, L., Sun, Y., Zhang, H., Cao, Y., & Zhang, J. (2023). Catalpol Ameliorates Myocardial I/R Injury Through PI3k/Akt/P53 Signaling-mediated Anti-autophagy and Anti-apoptosis. Pharmacognosy Magazine, 19(4), 946–953. https://doi.org/10.1177/09731296231189557
